Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display & Cocktail

27P - CD73 promotes pancreatic cancer cell progression through TNFR2/AKT and ERK signaling

Date

02 Mar 2020

Session

Poster Display & Cocktail

Presenters

Liangjing Zhou

Citation

Annals of Oncology (2020) 31 (suppl_1): S10-S13. 10.1016/annonc/annonc85

Authors

L. Zhou, S. Jia, L. Cao

Author affiliations

  • Department Of General Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, 310016 - Hangzhou/CN
More

Resources

Abstract 27P

Recent studies have shown that the non-enzymatic function of CD73 plays a key role in tumor progression, but this function of CD73 in pancreatic cancer cells has not been studied. Furthermore, little is still known about the mechanisms involved in CD73 regulation in tumors.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.